Publications
Here you will find a comprehensive collection of all publications of the Leibniz Institute of Virology up to the year 1974. Use the filter options on the left to search specifically by year, author, research unit and journal. The search field also allows you to explore specific topics.
1974 - 2025
Displaying results 1 to 7 of 7.
Search narrowed by:
Publication
| 2024
Orally bioavailable RORγ/DHODH dual host-targeting small molecules with broad-spectrum antiviral activity.
- Herrmann A, Gege C, Wangen C, Wagner S, Kögler M, Cordsmeier A, Irrgang P, Ip W-H, Weil T, Hunszinger V, Groß R, Heinen N, Pfaender S, Reuter S, Klopfleisch R, Uhlig N, Eberlein V, Issmail L, Grunwald T, Hietel B, Cynis H, Münch J, Sparrer KMJ, Ensser A, Tenbusch M, Dobner T, Vitt D, Kohlhof H, Hahn F
-
Antiviral Res,
Publication
| 2023
Thioxothiazolo[3,4-a]quinazoline derivatives inhibit the human cytomegalovirus alkaline nuclease.
- Zhang T, Potgieter TI, Kosche E, Rückert J, Ostermann E, Schulz T, Empting M, Brune W
-
Antiviral Res,
Publication
| 2022
Inhibition of p38 signaling curtails the SARS-CoV-2 induced inflammatory response but retains the IFN-dependent antiviral defense of the lung epithelial barrier.
- Faist A, Schloer S, Mecate-Zambrano A, Janowski J, Schreiber A, Boergeling Y, Conrad BCG, Kumar S, Toebben L, Schughart K, Baumgardt M, Kessler M, Hoenzke K, Hocke A, Trautmann M, Hartmann W, Kato H, Rescher U, Christersson A, Kuehn J, Mellmann A, Wolff T, Kuempers P, Rovas A, Wiewrodt R, Wiebe K, Barth P, Ludwig S, Brunotte L
-
Antiviral Res,
Publication
| 2018
Relevance of non-synonymous thymidine kinase mutations for antiviral resistance of recombinant herpes simplex virus type 2 strains.
- Brunnemann AK, Hoffmann A, Deinhardt-Emmer S, Nagel CH, Rose R, Fickenscher H, Sauerbrei A, Krumbholz A
-
Antiviral Res,
Publication
| 2014
Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
- Oestereich L, Lüdtke A, Wurr S, Rieger T, Muñoz-Fontela C, Günther S
-
Antiviral Res,
Publication
| 2014
A new class of synthetic anti-lipopolysaccharide peptides inhibits influenza A virus replication by blocking cellular attachment.
- Hoffmann J, Schneider C, Heinbockel L, Brandenburg K, Reimer R, Gabriel G
-
Antiviral Res,
Publication
| 2001
Structural and functional heterogeneity of naturally occurring hepatitis B virus variants.
- Burda MR, Günther S, Dandri M, Will H, Petersen J
-
Antiviral Res,
